The NPC Community is experiencing unprecedented investment and progress in developing treatments for the disease. Today, at least 13 companies have NPC programs underway, two of which are in later stages of regulatory review with the FDA.
A core of the Accelerator is to connect families and researchers to available and studied therapies and companies to researchers and families.
